|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1989; 13:57-62 © 1989 by the American College of Cardiology Foundation |
Cora and Webb Mading Department of Surgery, Baylor College of Medicine, Houston, Texas 77030.
Between July 1979 and December 1984, 785 patients received 815 St. Jude Medical valve prostheses. Valve-related mortality in the follow-up period was due to thromboembolism in seven cases, anticoagulant-related hemorrhage in three and perivalvular leak in two. Freedom from valve-related death or reoperation at 3 years was 96.4% for aortic valve replacement and 98.3% for mitral valve replacement. The overall rate of thromboembolism was 2.6%/patient-year with warfarin, 9.2%/patient-year with antiplatelet medication and 15.6%/patient-year in patients with no anticoagulant therapy. One episode of thrombotic obstruction of a mitral valve, in a patient receiving no anticoagulant therapy, resulted in an occurrence rate of such obstruction of 0.22%/patient-year. Valve replacement with the St. Jude valve produced excellent clinical results, but long-term anticoagulation with warfarin was required to minimize thromboembolic complications. The use of antiplatelet agents alone provided inadequate protection.
This article has been cited by other articles:
|
|
 |
|
  S. Torregrosa, J. Gomez-Plana, F. J. Valera, J. Caffarena, J. M. Maronas, F. Garcia-Sanchez, J. Peris, R. Frias, and J. M. Caffarena Long-term clinical experience with the omnicarbon prosthetic valve Ann. Thorac. Surg., September 1, 1999; 68(3): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Tam, R. G. Masters, I. G. Burwash, A. D. Mayhew, and K.-L. Chan Management of Patients With Mild Aortic Stenosis Undergoing Coronary Artery Bypass Grafting Ann. Thorac. Surg., May 1, 1998; 65(5): 1215 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L-F. Debetaz, P. Ruchat, M. Hurni, A. Fischer, F. Stumpe, H. Sadeghi, G. van Melle, and J-J. Goy ST. JUDE MEDICAL VALVE PROSTHESIS: AN ANALYSIS OF LONG-TERM OUTCOME AND PROGNOSTIC FACTORS J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 134 - 148. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Cochran, K. S. Kunzelman, A. C. Eddy, B. O. Hofer, and E. D. Verrier Modified conduit preparation creates a pseudosinus in an aortic valve-sparing procedure for aneurysm of the ascending aorta J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1049 - 1058. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Sturzenegger, J. H. Beer, and F. Rihs Monitoring Combined Antithrombotic Treatments in Patients With Prosthetic Heart Valves Using Transcranial Doppler and Coagulation Markers Stroke, January 1, 1995; 26(1): 63 - 69. [Abstract] [Full Text]
|
|
|
|
|
|
S. Khan, A. Chaux, J. Matloff, C. Blanche, M. DeRobertis, R. Kass, T. P. Tsai, A. Trento, S. Nessim, R. Gray, et al. The St. Jude Medical valveExperience with 1000 cases J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1010 - 1020. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ibrahim, H. O'Kane, J. Cleland, D. Gladstone, M. Sarsam, and C. Patterson The St. Jude Medical prosthesisA thirteen-year experience J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 221 - 230. [Abstract] [Full Text]
|
|
|
|
|
|
J. Fernandez, G. W. Laub, M. S. Adkins, W. A. Anderson, C. Chen, B. M. Bailey, L. M. Nealon, and L. B. McGrath Early and late-phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 394 - 407. [Abstract] [Full Text]
|
|
|
|
 |
|
 ANTICOAGULATION NECESSARY WITH ST. JUDE VALVE PROSTHESIS Journal Watch (General), January 24, 1989; 1989(124): 1 - 1. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
